In models of atherosclerosis, Gal-9 deficiency reduced plaque burden and macrophage content, while exogenous Gal-9 enhanced efferocytosis by phagocytes causing reduced inflammation [50], [53], [54]. This evidence concerns the gene LGALS9 and atherosclerosis.